Home/Filings/4/0001209191-22-049802
4//SEC Filing

Sanford Svai S 4

Accession 0001209191-22-049802

CIK 0001856725other

Filed

Sep 12, 8:00 PM ET

Accepted

Sep 13, 8:44 PM ET

Size

4.9 KB

Accession

0001209191-22-049802

Insider Transaction Report

Form 4
Period: 2022-09-09
Sanford Svai S
Chief Financial Officer
Transactions
  • Tax Payment

    Class A Common Stock

    2022-09-09$9.89/sh18,362$181,600120,738 total
Footnotes (1)
  • [F1]Represents the number of shares withheld by and surrendered to the Issuer on September 9, 2022, to satisfy tax withholding obligations that arose in connection with the vesting of the restricted stock units granted to Mr. Sanford on September 9, 2021.

Issuer

Rani Therapeutics Holdings, Inc.

CIK 0001856725

Entity typeother

Related Parties

1
  • filerCIK 0001591411

Filing Metadata

Form type
4
Filed
Sep 12, 8:00 PM ET
Accepted
Sep 13, 8:44 PM ET
Size
4.9 KB